Cheryl Oncken1,2, Karen A Ricci3,4, Chia-Ling Kuo5, Ellen Dornelas1,6, Henry R Kranzler7, Heather Z Sankey3. 1. Department of Medicine, University of Connecticut School of Medicine, Farmington, CT. 2. Department of Obstetrics and Gynecology, University of Connecticut School of Medicine, Farmington, CT. 3. Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA. 4. Adjunct Staff, RAND Corporation, Santa Monica, CA. 5. Connecticut Institute for Clinical and Translational Science, Department of Community Medicine and Health Care, Institute for Systems Genomics, Farmington, CT. 6. Division of Oncology, Department of Medicine, Hartford Hospital, Hartford, CT. 7. Department of Psychiatry, University of Pennsylvania Perelman School of Medicine and Crescenz VAMC, Philadelphia, PA.
Abstract
INTRODUCTION: Electronic cigarette use is rapidly gaining in popularity. However, little is known about correlates and reasons for electronic cigarette use by women of reproductive age, a group for which the safety and efficacy of electronic cigarette use is of particular interest. METHODS: As part of a clinical trial for smoking cessation, we surveyed pregnant smokers about their lifetime use of electronic cigarettes, previous use of any adjunctive treatments for smoking cessation, and use of electronic cigarettes during pregnancy. We examined associations between electronic cigarette use and participant characteristics. RESULTS: Fifty-three percent (55/103) of participants had previously tried electronic cigarettes. Ever users smoked more cigarettes per day before pregnancy (p = .049), had a greater number of previous quit attempts (p = .033), and were more likely to identify as being Hispanic or non-Hispanic white than never users (p = .027). Fifteen percent of participants (15/103) reported previous use of electronic cigarettes for smoking cessation, which was more common than the use of any specific FDA-approved smoking cessation medication. Fourteen percent of participants (14/103) reported electronic cigarette use during pregnancy, most commonly to quit smoking. A history of substance abuse (p = .043) and more previous quit attempts (p = .018) were associated with electronic cigarette use during pregnancy. CONCLUSIONS: Use of electronic cigarettes to quit smoking may be common in women of reproductive age, including those who are pregnant. More research is needed to determine the risks and benefits of electronic cigarette use in this population of smokers. IMPLICATIONS: This study shows that electronic cigarettes are used by women of reproductive age, including pregnant smokers. The implications of this finding are that there is an urgent need to examine the risks and benefits of electronic cigarette use, especially by pregnant women. The study also shows that electronic cigarettes are commonly used as a smoking cessation aid in women of reproductive age. The greater likelihood of electronic cigarette use compared to proven adjunctive smoking treatments suggests that electronic cigarettes should be examined as a potential aid to cessation in this population.
INTRODUCTION: Electronic cigarette use is rapidly gaining in popularity. However, little is known about correlates and reasons for electronic cigarette use by women of reproductive age, a group for which the safety and efficacy of electronic cigarette use is of particular interest. METHODS: As part of a clinical trial for smoking cessation, we surveyed pregnant smokers about their lifetime use of electronic cigarettes, previous use of any adjunctive treatments for smoking cessation, and use of electronic cigarettes during pregnancy. We examined associations between electronic cigarette use and participant characteristics. RESULTS: Fifty-three percent (55/103) of participants had previously tried electronic cigarettes. Ever users smoked more cigarettes per day before pregnancy (p = .049), had a greater number of previous quit attempts (p = .033), and were more likely to identify as being Hispanic or non-Hispanic white than never users (p = .027). Fifteen percent of participants (15/103) reported previous use of electronic cigarettes for smoking cessation, which was more common than the use of any specific FDA-approved smoking cessation medication. Fourteen percent of participants (14/103) reported electronic cigarette use during pregnancy, most commonly to quit smoking. A history of substance abuse (p = .043) and more previous quit attempts (p = .018) were associated with electronic cigarette use during pregnancy. CONCLUSIONS: Use of electronic cigarettes to quit smoking may be common in women of reproductive age, including those who are pregnant. More research is needed to determine the risks and benefits of electronic cigarette use in this population of smokers. IMPLICATIONS: This study shows that electronic cigarettes are used by women of reproductive age, including pregnant smokers. The implications of this finding are that there is an urgent need to examine the risks and benefits of electronic cigarette use, especially by pregnant women. The study also shows that electronic cigarettes are commonly used as a smoking cessation aid in women of reproductive age. The greater likelihood of electronic cigarette use compared to proven adjunctive smoking treatments suggests that electronic cigarettes should be examined as a potential aid to cessation in this population.
Authors: Thomas H Brandon; Maciej L Goniewicz; Nasser H Hanna; Dorothy K Hatsukami; Roy S Herbst; Jennifer A Hobin; Jamie S Ostroff; Peter G Shields; Benjamin A Toll; Courtney A Tyne; Kasisomayajula Viswanath; Graham W Warren Journal: J Clin Oncol Date: 2015-01-08 Impact factor: 44.544
Authors: Hayden McRobbie; Anna Phillips; Maciej L Goniewicz; Katie Myers Smith; Oliver Knight-West; Dunja Przulj; Peter Hajek Journal: Cancer Prev Res (Phila) Date: 2015-09
Authors: Abby Hunter; Judith Yargawa; Caitlin Notley; Michael Ussher; Alex Bobak; Rachael L Murray; Srabani Nath; Sue Cooper Journal: Nicotine Tob Res Date: 2021-02-16 Impact factor: 4.244
Authors: Olufunmilayo H Obisesan; Albert D Osei; S M Iftekhar Uddin; Omar Dzaye; Miguel Cainzos-Achirica; Mohammadhassan Mirbolouk; Olusola A Orimoloye; Garima Sharma; Mahmoud Al Rifai; Andrew Stokes; Aruni Bhatnagar; Omar El Shahawy; Emelia J Benjamin; Andrew P DeFilippis; Michael J Blaha Journal: Am J Prev Med Date: 2020-04-30 Impact factor: 5.043
Authors: Allison N Kurti; Janice Y Bunn; Katherine Tang; Tyler Nighbor; Diann E Gaalema; Victoria Coleman-Cowger; Sulamunn R M Coleman; Stephen T Higgins Journal: Drug Alcohol Depend Date: 2019-12-10 Impact factor: 4.492
Authors: Allison N Kurti; Ryan Redner; Janice Y Bunn; Katherine Tang; Tyler Nighbor; Alexa A Lopez; Diana R Keith; Andrea C Villanti; Cassandra A Stanton; Diann E Gaalema; Nathan J Doogan; Antonio Cepeda-Benito; Megan E Roberts; Julie Phillips; Maria A Parker; Amanda J Quisenberry; Stephen T Higgins Journal: Prev Med Date: 2018-08-23 Impact factor: 4.018